Addiction (BASKET)

Desire, disease, and the origins of the dopaminergic system.
[18283047] Schizophr Bull 34(2): 212-9 (2008)

Drugs of abuse and brain gene expression.
[10511013] Psychosom Med 61(5): 630-50 (1999)

The mechanistic classification of addictive drugs.
[17105338] PLoS Med 3(11): e437 (2006)

Withdrawal strategies for outpatients. Alcohol, benzodiazepine, barbiturate, and opiate addictions.
[8828877] Can Fam Physician 42(-): 1745-52 (1996)

Substance use disorders and the orbitofrontal cortex: systematic review of behavioural decision-making and neuroimaging studies.
[16135857] Br J Psychiatry 187(-): 209-20 (2005)

Neurobiology of addiction and implications for treatment.
[12562734] Br J Psychiatry 182(-): 97-100 (2003)

Behavioral therapies for drug abuse.
[16055766] Am J Psychiatry 162(8): 1452-60 (2005)

Medication development for addictive disorders: the state of the science.
[16055764] Am J Psychiatry 162(8): 1432-40 (2005)

Anticraving medications for relapse prevention: a possible new class of psychoactive medications.
[16055763] Am J Psychiatry 162(8): 1423-31 (2005)

Addiction: a disease of learning and memory.
[16055762] Am J Psychiatry 162(8): 1414-22 (2005)

The neural basis of addiction: a pathology of motivation and choice.
[16055761] Am J Psychiatry 162(8): 1403-13 (2005)

What do we know about drug addiction?
[16055760] Am J Psychiatry 162(8): 1401-2 (2005)

Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.
[12359667] Am J Psychiatry 159(10): 1642-52 (2002)

Behavioral perspectives on the neuroscience of drug addiction.
[16596985] J Exp Anal Behav 84(3): 667-81 (2005)

Neuronal substrates of relapse to cocaine-seeking behavior: role of prefrontal cortex.
[16596984] J Exp Anal Behav 84(3): 653-66 (2005)

Assessing addiction: concepts and instruments.
[18292706] Addict Sci Clin Pract 4(1): 19-31 (2007)

Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration.
[15466321] Learn Mem 11(5): 648-57 (2004)

GABAergic mechanisms of opiate reinforcement .
[12217944] Alcohol Alcohol 37(5): 485-94 (2002)

A role for brain stress systems in addiction.
[18614026] Neuron 59(1): 11-34 (2008)

Cocaine-paired cues activate aversive representations in accumbens neurons.
[18341985] Neuron 57(5): 633 (2008)

Memory and addiction: shared neural circuitry and molecular mechanisms.
[15450168] Neuron 44(1): 161-79 (2004)

Banburismus and the brain: decoding the relationship between sensory stimuli, decisions, and reward.
[12383783] Neuron 36(2): 299-308 (2002)

Reward, motivation, and reinforcement learning.
[12383782] Neuron 36(2): 285-98 (2002)

Getting formal with dopamine and reward.
[12383780] Neuron 36(2): 241-63 (2002)

Brain reward circuitry: insights from unsensed incentives.
[12383779] Neuron 36(2): 229-40 (2002)

Experimental genetic approaches to addiction.
[12383778] Neuron 36(2): 213-28 (2002)

The need to feed: homeostatic and hedonic control of eating.
[12383777] Neuron 36(2): 199-211 (2002)

Reward and decision.
[12383776] Neuron 36(2): 193-8 (2002)

Neuroscience of addiction.
[9768834] Neuron 21(3): 467-76 (1998)

The role of acetylcholine in cocaine addiction.
[17928814] Neuropsychopharmacology 33(8): 1779-97 (2008)

There and back again: a tale of norepinephrine and drug addiction.
[17164822] Neuropsychopharmacology 32(7): 1433-51 (2007)

Drug addiction, dysregulation of reward, and allostasis.
[11120394] Neuropsychopharmacology 24(2): 97-129 (2001)

Regulation of psychostimulant-induced signaling and gene expression in the striatum.
[18221378] J Neurochem 104(6): 1440-9 (2008)

Pharmacologic treatments for opioid dependence: detoxification and maintenance options.
[18286804] Dialogues Clin Neurosci 9(4): 455-70 (2007)

Pharmacogenetic aspects of addictive behaviors.
[18286803] Dialogues Clin Neurosci 9(4): 447-54 (2007)

Therapeutic options and challenges for substances of abuse.
[18286802] Dialogues Clin Neurosci 9(4): 431-45 (2007)

Opioids, dopamine, stress, and the addictions.
[18286797] Dialogues Clin Neurosci 9(4): 363-78 (2007)

Historical and cultural aspects of man's relationship with addictive drugs.
[18286796] Dialogues Clin Neurosci 9(4): 355-61 (2007)

Neurorobiology and evidence-based biological treatments for substance abuse disorders.
[17075558] CNS Spectr 11(11): 864-77 (2006)

Perspectives on current directions in the neurobiology of addiction disorders relevant to genetic risk factors.
[17075557] CNS Spectr 11(11): 855-62 (2006)

The application of mindfulness-based cognitive interventions in the treatment of co-occurring addictive and mood disorders.
[17075556] CNS Spectr 11(11): 829-51 (2006)

Ultrarapid opiate detoxification: a review.
[12944440] Can J Anaesth 50(7): 663-71 (2003)

The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology.
[18223661] Br J Pharmacol 153 Suppl 1(-): S438-45 (2008)

Addiction: the clinical interface.
[18414399] Br J Pharmacol 154(2): 397-405 (2008)

Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
[15734726] Pharmacol Rev 57(1): 1-26 (2005)

Neurobiology of relapse to heroin and cocaine seeking: a review.
[11870259] Pharmacol Rev 54(1): 1-42 (2002)

The role of corticotropin-releasing factor in drug addiction.
[11356984] Pharmacol Rev 53(2): 209-43 (2001)

Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.
[10049999] Pharmacol Rev 51(1): 83-133 (1999)

Neurobiology of cannabis addiction.
[19552052] Indian J Physiol Pharmacol 52(3): 217-32 (2008)

Review. Neurobiological mechanisms for opponent motivational processes in addiction.
[18653439] Philos Trans R Soc Lond B Biol Sci 363(1507): 3113-23 (2008)

Review. Transcriptional mechanisms of addiction: role of DeltaFosB.
[18640924] Philos Trans R Soc Lond B Biol Sci 363(1507): 3245-55 (2008)

Review. Positron emission tomography imaging studies of dopamine receptors in primate models of addiction.
[18640923] Philos Trans R Soc Lond B Biol Sci 363(1507): 3223-32 (2008)

Review. Context-induced relapse to drug seeking: a review.
[18640922] Philos Trans R Soc Lond B Biol Sci 363(1507): 3233-43 (2008)

Review. Psychological and neural mechanisms of relapse.
[18640921] Philos Trans R Soc Lond B Biol Sci 363(1507): 3147-58 (2008)

Review. The incentive sensitization theory of addiction: some current issues.
[18640920] Philos Trans R Soc Lond B Biol Sci 363(1507): 3137-46 (2008)

Review. Neurobiology of nicotine dependence.
[18640919] Philos Trans R Soc Lond B Biol Sci 363(1507): 3159-68 (2008)

Review. Genetics of addictions: strategies for addressing heterogeneity and polygenicity of substance use disorders.
[18640915] Philos Trans R Soc Lond B Biol Sci 363(1507): 3213-22 (2008)

Review. Evidence-based treatments of addiction.
[18640914] Philos Trans R Soc Lond B Biol Sci 363(1507): 3277-86 (2008)

Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction.
[18640910] Philos Trans R Soc Lond B Biol Sci 363(1507): 3125-35 (2008)

Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings.
[18640909] Philos Trans R Soc Lond B Biol Sci 363(1507): 3181-9 (2008)

The neurosurgical treatment of addiction.
[18590382] Neurosurg Focus 25(1): E5 (2008)

Molecular and cellular basis of addiction.
[9311927] Science 278(5335): 58-63 (1997)

Evaluation of motivational effects induced by intracranial self-stimulation behavior.
[20975759] Acta Med Okayama 64(5): 267-75 (2010)

Inhalant use and inhalant use disorders in the United States.
[22003419] Addict Sci Clin Pract 6(1): 18-31 (2011)

Anabolic-androgenic steroid dependence: an emerging disorder.
[19922565] Addiction 104(12): 1966-78 (2009)

A vision of the next generation of behavioral therapies research in the addictions.
[17523974] Addiction 102(6): 850-62; discussion 863-9 (2007)

Behavioral intervention to promote smoking cessation and prevent weight gain: a systematic review and meta-analysis.
[19549058] Addiction 104(9): 1472-86 (2009)

Drug addiction as drive satisfaction ("antidrive") dysfunction.
[12201032] Acta Neurobiol Exp (Wars) 62(2): 111-7 (2002)

Waterpipe tobacco smoking: an emerging health crisis in the United States.
[20001185] Am J Health Behav 34(3): 275-85 (2010)

Neurobiological processes in adolescent addictive disorders.
[18214718] Am J Addict 17(1): 6-23 (2008)

Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.
[19462300] Am J Drug Alcohol Abuse 35(3): 161-77 (2009)

A new anatomical framework for neuropsychiatric disorders and drug abuse.
[14514480] Am J Psychiatry 160(10): 1726-39 (2003)

Predisposition to addiction: pharmacokinetics, pharmacodynamics, and brain circuitry.
[12505792] Am J Psychiatry 160(1): 1-2 (2003)

Conditioned place preference induced by licit drugs: establishment, extinction, and reinstatement.
[19082419] ScientificWorldJournal 8(-): 1228-45 (2008)

Role of brain dopamine in food reward and reinforcement.
[16874930] Philos Trans R Soc Lond B Biol Sci 361(1471): 1149-58 (2006)

Androgen abuse in athletes: detection and consequences.
[20139230] J Clin Endocrinol Metab 95(4): 1533-43 (2010)

Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy).
[18198474] J Pharmacol Sci 106(1): 2-8 (2008)

Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.
[18198473] J Pharmacol Sci 106(1): 15-21 (2008)

Neuropsychotoxicity of abused drugs: involvement of matrix metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-2 in methamphetamine-induced behavioral sensitization and reward in rodents.
[18198472] J Pharmacol Sci 106(1): 9-14 (2008)

A neuropeptide-centric view of psychostimulant addiction.
[18414383] Br J Pharmacol 154(2): 343-57 (2008)

Genetic factors influencing alcohol dependence.
[18362899] Br J Pharmacol 154(2): 275-87 (2008)

Inhalant abuse among adolescents: neurobiological considerations.
[18332858] Br J Pharmacol 154(2): 316-26 (2008)

The addicted human brain: insights from imaging studies.
[12750391] J Clin Invest 111(10): 1444-51 (2003)

Intense sweetness surpasses cocaine reward.
[17668074] PLoS One 2(8): e698 (2007)

The epigenetic landscape of addiction.
[21272014] Ann N Y Acad Sci 1216(-): 99-113 (2011)

Hippocampus, amygdala, and stress: interacting systems that affect susceptibility to addiction.
[21272015] Ann N Y Acad Sci 1216(-): 114-21 (2011)

Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse.
[20201850] Ann N Y Acad Sci 1187(-): 129-39 (2010)

Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.
[20201852] Ann N Y Acad Sci 1187(-): 148-71 (2010)

Molecular mechanisms of psychostimulant addiction.
[19403004] Chang Gung Med J 32(2): 148-54 (2009)

A 50-year-old woman addicted to heroin: review of treatment of heroin addiction.
[18594026] JAMA 300(3): 314-21 (2008)

Addiction and substance abuse in anesthesiology.
[18946304] Anesthesiology 109(5): 905-17 (2008)

Animal models and brain circuits in drug addiction.
[17200461] Mol Interv 6(6): 339-44 (2006)

Buprenorphine: new treatment of opioid addiction in primary care.
[21402963] Can Fam Physician 57(3): 281-9 (2011)

Managing opioid dependence. Comparing buprenorphine with methadone.
[12901482] Can Fam Physician 49(-): 876-7 (2003)

New insights on the subcortical representation of reward.
[18674617] Curr Opin Neurobiol 18(2): 203-8 (2008)

Dynorphin and the pathophysiology of drug addiction.
[17868902] Pharmacol Ther 116(2): 306-21 (2007)

Anti-relapse medications: preclinical models for drug addiction treatment.
[19683019] Pharmacol Ther 124(2): 235-47 (2009)

Behavioral characteristics and neurobiological substrates shared by Pavlovian sign-tracking and drug abuse.
[18234349] Brain Res Rev 58(1): 121-35 (2008)

A ventral tegmental CRF-glutamate-dopamine interaction in addiction.
[19800323] Brain Res 1314(-): 38-43 (2010)

Molecular and genetic substrates linking stress and addiction.
[19900417] Brain Res 1314(-): 219-34 (2010)

The role of CRF and CRF-related peptides in the dark side of addiction.
[19912996] Brain Res 1314(-): 3-14 (2010)

Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.
[19914222] Brain Res 1314(-): 235-52 (2010)

Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.
[20026088] Brain Res 1314(-): 145-61 (2010)

Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking.
[19631614] Brain Res 1314(-): 15-28 (2010)

Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors.
[19699187] Brain Res 1314(-): 206-18 (2010)

Role of orexin/hypocretin in dependence and addiction.
[19699189] Brain Res 1314(-): 130-8 (2010)

The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.
[19716811] Brain Res 1314(-): 44-55 (2010)

Brain-derived neurotrophic factor and cocaine addiction.
[19732758] Brain Res 1314(-): 183-93 (2010)

Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction.
[19800322] Brain Res 1314(-): 29-37 (2010)

Brain stress systems in the amygdala and addiction.
[19332030] Brain Res 1293(-): 61-75 (2009)

Cannabis use by children and young people.
[16861487] Arch Dis Child 91(8): 692-5 (2006)

Linking cocaine to endoplasmic reticulum in striatal neurons: role of glutamate receptors.
[21808746] Basal Ganglia 1(2): 59-63 (2011)

Homers regulate drug-induced neuroplasticity: implications for addiction.
[17765204] Biochem Pharmacol 75(1): 112-33 (2008)

The neurobiology and genetics of impulse control disorders: relationships to drug addictions.
[17719013] Biochem Pharmacol 75(1): 63-75 (2008)

Glutamatergic substrates of drug addiction and alcoholism.
[17706608] Biochem Pharmacol 75(1): 218-65 (2008)

Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction.
[17632086] Biochem Pharmacol 75(1): 323-33 (2008)

Update in addiction medicine for the primary care clinician.
[18830761] J Gen Intern Med 23(12): 2112-6 (2008)

Role of endocannabinoids in regulating drug dependence.
[19300605] Neuropsychiatr Dis Treat 3(6): 711-21 (2007)

Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder.
[18789354] Neurosci Biobehav Rev 33(5): 690-8 (2009)

Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.
[20338186] Physiol Behav 100(5): 419-28 (2010)

Development of pharmacotherapies for drug addiction: a Rosetta stone approach.
[19483710] Nat Rev Drug Discov 8(6): 500-15 (2009)

Modulation of the endocannabinoid system: therapeutic potential against cocaine dependence.
[17945506] Pharmacol Res 56(5): 406-17 (2007)

Endogenous modulators for drug dependence.
[18758051] Biol Pharm Bull 31(9): 1635-8 (2008)

The effects of waterpipe tobacco smoking on health outcomes: a systematic review.
[20207606] Int J Epidemiol 39(3): 834-57 (2010)

Animal models of substance abuse and addiction: implications for science, animal welfare, and society.
[20579432] Comp Med 60(3): 177-88 (2010)

Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.
[20047160] Curr Opin Investig Drugs 11(1): 63-71 (2010)

Cognitive enhancers in the treatment of substance use disorders: clinical evidence.
[21557964] Pharmacol Biochem Behav 99(2): 285-94 (2011)

Some rewarding effects of androgens may be mediated by actions of its 5alpha-reduced metabolite 3alpha-androstanediol.
[17112575] Pharmacol Biochem Behav 86(2): 354-67 (2007)

Evidence for opioid involvement in the motivation to sing.
[19995531] J Chem Neuroanat 39(2): 141-50 (2010)

Imaging the addicted human brain.
[17514067] Sci Pract Perspect 3(2): 4-16 (2007)

Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory.
[19434554] Pharmacopsychiatry 42 Suppl 1(-): S32-41 (2009)

Relapse prevention for addictive behaviors.
[21771314] Subst Abuse Treat Prev Policy 6(-): 17 (2011)

Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications.
[20188494] Drug Alcohol Depend 109(1-3): 6-13 (2010)

Neurobiologic processes in drug reward and addiction.
[15764467] Harv Rev Psychiatry 12(6): 305-20 (2004)

Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain.
[17532111] Prog Neurobiol 83(5): 332-47 (2007)

Substance use disorders: do males and females have differential vulnerability?
[20686131] J Neuropsychiatry Clin Neurosci 22(3): iv (2010)

Use of zebrafish as a model to understand mechanisms of addiction and complex neurobehavioral phenotypes.
[20493262] Neurobiol Dis 40(1): 66-72 (2010)

The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons.
[21811439] Front Neuroanat 5(-): 41 (2011)

Anabolic-androgenic steroid dependence? Insights from animals and humans.
[18275992] Front Neuroendocrinol 29(4): 490-506 (2008)

Structural, metabolic, and functional brain abnormalities as a result of prenatal exposure to drugs of abuse: evidence from neuroimaging.
[20978945] Neuropsychol Rev 20(4): 376-97 (2010)

Theory-based processes that promote the remission of substance use disorders.
[17254686] Clin Psychol Rev 27(5): 537-51 (2007)

Advances in adolescent substance abuse treatment.
[21701838] Curr Psychiatry Rep 13(5): 416-21 (2011)

Novel medications to treat addictive disorders.
[18803912] Curr Psychiatry Rep 10(5): 392-8 (2008)

Psychiatric complications of anabolic steroid abuse.
[16000671] Psychosomatics 46(4): 285-90 (2005)

The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.
[20352414] Psychopharmacology (Berl) 210(2): 121-35 (2010)

Serotonergic mechanisms in addiction-related memories.
[18639587] Behav Brain Res 195(1): 39-53 (2008)

The role of orbitofrontal cortex in drug addiction: a review of preclinical studies.
[17719014] Biol Psychiatry 63(3): 256-62 (2008)

Anti-addiction vaccines.
[22003367] F1000 Med Rep 3(-): 20 (2011)

Vaccines against morphine/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors.
[19242094] Hum Vaccin 5(4): 214-29 (2009)

Development of active and passive human vaccines to treat methamphetamine addiction.
[19276653] Hum Vaccin 5(4): 206-13 (2009)

Vaccines for cocaine abuse.
[19276665] Hum Vaccin 5(4): 194-9 (2009)

Neurobehavioral effects of acute exposure to four solvents: meta-analyses.
[19339666] Toxicol Sci 109(2): 296-305 (2009)

Glutamatergic targets for enhancing extinction learning in drug addiction.
[21629446] Curr Neuropharmacol 8(4): 394-408 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Addiction (BASKET).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Addiction (BASKET).php on line 92